Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children

Diabetologia

Volumn 56, Issue 7, 2013, Pages 1615-1622

  Achenbach, P ^a,b,c   Hummel, M ^c   Thumer L ^b   Boerschmann, H ^c   Hofelmann D ^a,b   Ziegler, A G ^a,b,c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Forschergruppe Diabetes EV   (Germany)

Author keywords

Islet autoantibody; Progression; Susceptibility genes; Type 1 diabetes

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPIDERMAL GROWTH FACTOR RECEPTOR 3; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DQ ANTIGEN; HLA DR ANTIGEN; INSULIN; INSULIN ANTIBODY; INSULINOMA ASSOCIATED ANTIGEN 2; INTERLEUKIN 10; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; UNCLASSIFIED DRUG; ZINC TRANSPORTER 8 PROTEIN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CD25 GENE; CHILD; CLINICAL FEATURE; COBL GENE; COHORT ANALYSIS; CTLA4 GENE; DISEASE COURSE; DNA DETERMINATION; ERBB3 GENE; FOLLOW UP; GENE FUNCTION; GENE STRUCTURE; GENETIC ANALYSIS; GENOTYPE; HLA DQ GENE; HLA DR GENE; HUMAN; IFIH1 GENE; IL10 GENE; IL18RAP GENE; IL2 GENE; INS GENE; INSULIN DEPENDENT DIABETES MELLITUS; KIAA0350 GENE; LONGITUDINAL STUDY; PANCREAS ISLET; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PTPN2 GENE; PTPN22 GENE; SCHOOL CHILD; SEROCONVERSION; SH2B3 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SUPPRESSOR GENE; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; AUTOANTIBODIES; CATION TRANSPORT PROTEINS; CHILD; CHILD, PRESCHOOL; CTLA-4 ANTIGEN; DEAD-BOX RNA HELICASES; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; INSULIN; INTERLEUKIN-10; INTERLEUKIN-18 RECEPTOR BETA SUBUNIT; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LECTINS, C-TYPE; MALE; MICROFILAMENT PROTEINS; MONOSACCHARIDE TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; PROTEINS; RECEPTOR, ERBB-3; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8;

EID: 84878847275     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2896-y     Document Type: Article

References (45)

1. Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221-229
2. Achenbach P, Lampasona V, Landherr U et al (2009) Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 52:1881-1888
3. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G, EURODIAB Study Group (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373:2027-2033
4. Hummel M, Bonifacio E, Schmid S, Walter M, Knopff A, Ziegler AG (2004) Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med 140:882-886
5. Steck AK, Johnson K, Barriga KJ et al (2011) Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young. Diabetes Care 34:1397-1399
6. Parikka V, Nanto-Salonen K, Saarinen M et al (2012) Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia 55:1926-1936
7. Ziegler AG, Pflueger M, Winkler C et al (2011) Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children. J Autoimmun 37:3-7
8. Bingley PJ, Christie MR, Bonifacio E et al (1994) Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43:1304-1310
9. Verge CF, Gianani R, Kawasaki E et al (1996) Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933
10. Ziegler AG, Hummel M, Schenker M, Bonifacio E (1999) Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48:460-468
11. Puavilai G, Chanprasertyotin S, Sriphrapradaeng A (1999) Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. Diabetes Res Clin Pract 44:21-26
12. Torn C, Mueller PW, Schlosser M, Bonifacio E, Bingley PJ, Laboratories P (2008) Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 51:846-852
13. Schlosser M, Mueller PW, Torn C, Bonifacio E, Bingley PJ, Laboratories P (2010) Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies. Diabetologia 53:2611-2620
14. Lampasona V, Schlosser M, Mueller PW et al (2011) Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8. Clin Chem 57:1693-1702
15. Walter M, Albert E, Conrad M et al (2003) IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of type 1 diabetes and associated autoimmunity. Diabetologia 46:712-720
16. Barrett JC, Clayton DG, Concannon P et al (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41:703-707
17. Winkler C, Krumsiek J, Lempainen J et al (2012) A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes. Genes Immun 13:549-555
18. Agresti A, Mehta CR, Patel NR (1990) Exact inference for contingency tables with ordered categories. JASA 85:453-458
19. Akaike H (1974) A new look at the statistical model identification. IEEE Trans Autom Control 19:716-723
20. Sosenko JM, Krischer JP, Palmer JP et al (2008) A risk score for type 1 diabetes derived from autoantibody-positive participants in the Diabetes Prevention Trial-Type 1. Diabetes Care 31:528-533
21. Bingley PJ (2010) Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab 95:25-33
22. Kulmala P, Savola K, Petersen JS et al (1998) Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J Clin Invest 101:327-336
23. Decochez K, de Leeuw IH, Keymeulen B et al (2002) IA-2 autoantibodies predict impending type I diabetes in siblings of patients. Diabetologia 45:1658-1666
24. Achenbach P, Warncke K, Reiter J et al (2004) Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 53:384-392
25. Bonifacio E, Bingley PJ, Shattock M et al (1990) Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335:147-149
26. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E (2004) Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 114:589-597
27. Mayr A, Schlosser M, Grober N et al (2007) GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes. Diabetes 56:1527-1533
28. Krause S, Chmiel R, Bonifacio E et al (2012) IA-2 autoantibody affinity in children at risk for type 1 diabetes. Clin Immunol 145:224-229
29. Polychronakos C, Li Q (2011) Understanding type 1 diabetes through genetics: advances and prospects. Nat Rev Genet 12:781-792
30. Todd JA (2010) Etiology of type 1 diabetes. Immunity 32:457-467
31. Dendrou CA, Plagnol V, Fung E et al (2009) Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat Genet 41:1011-1015
32. Tang Q, Adams JY, Penaranda C et al (2008) Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28:687-697
33. Long SA, Cerosaletti K, Bollyky PL et al (2010) Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T cells of type 1 diabetic subjects. Diabetes 59:407-415
34. Yamanouchi J, Rainbow D, Serra P et al (2007) Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 39:329-337
35. Sgouroudis E, Albanese A, Piccirillo CA (2008) Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice. J Immunol 181:6283-6292
36. Howson JM, Cooper JD, Smyth DJ et al (2012) Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetes. Diabetes 61:3012-3017
37. Kurreeman FA, Schonkeren JJ, Heijmans BT, Toes RE, Huizinga TW (2004) Transcription of the IL10 gene reveals allele-specific regulation at the mRNA level. Hum Mol Genet 13:1755-1762
38. Smyth DJ, Cooper JD, Bailey R et al (2006) A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 38:617-619
39. Nejentsev S, Walker N, Riches D, Egholm M, Todd JA (2009) Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324:387-389
40. Smyth DJ, Plagnol V, Walker NM et al (2008) Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 359:2767-2777
41. Vang T, Congia M, Macis MD et al (2005) Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 37:1317-1319
42. Nejentsev S, Howson JM, Walker NM et al (2007) Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450:887-892
43. von Herrath M (2009) Diabetes: a virus-gene collaboration. Nature 459:518-519
44. Smyth DJ, Cooper JD, Howson JM et al (2011) FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection. Diabetes 60:3081-3084
45. MacFarlane AJ, Strom A, Scott FW (2009) Epigenetics: deciphering how environmental factors may modify autoimmune type 1 diabetes. Mamm Genome 20:624-632